Archive · 30 Jul 2026
Mankind Pharma Q1 FY27 Profit Falls 21%
Mankind Pharma, a drug company in India, said its profit for the first quarter of fiscal year 2027 was lower than last year.
The company earned about ₹558 crore, down from ₹704 crore a year earlier.
Its sales were also a bit lower, and it spent more money, especially on employee benefits.
The earnings per share dropped from ₹17 to ₹13.5.
The company also gave a guarantee to its vaccine subsidiary and sold a hospital business for ₹49 crore.
Net profit fell 21% to ₹558.49 crore for Q1 FY27
Revenue dropped to ₹2,964.05 crore from ₹3,027.67 crore
Total expenses rose to ₹2,241.44 crore, up from ₹2,138.77 crore
Basic EPS decreased to ₹13.53 from ₹17.06
Company issued a corporate guarantee to Bharat Serums and Vaccines Limited and sold its stake in Broadway Hospitality Services for ₹49 crore
- Who
- Mankind Pharma Limited
- What
- reported Q1 FY27 financial results
- When
- quarter ended 30 June 2026
- Where
- Mumbai, India
- Why
- to disclose quarterly performance to investors
- Net profit
- ₹558.49 crore
- Revenue
- ₹2,964.05 crore
- Total expenses
- ₹2,241.44 crore
- Basic EPS
- ₹13.53
- Divestment proceeds
- ₹49 crore